• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

Recent Advances in the Study of Benzenepropanol, 2,4-dichloro-α-ethyl- (CAS: 1251247-67-2) and Its Applications in Chemical Biology and Medicine

The compound Benzenepropanol, 2,4-dichloro-α-ethyl- (CAS: 1251247-67-2) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. This research briefing aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential use in drug development. The information presented herein is based on a comprehensive review of recent peer-reviewed publications, patent filings, and industry reports.

Recent studies have highlighted the role of Benzenepropanol, 2,4-dichloro-α-ethyl- as a key intermediate in the synthesis of novel bioactive molecules. Its structural features, including the presence of dichloro and ethyl substituents, make it a versatile scaffold for further chemical modifications. Researchers have successfully utilized this compound to develop derivatives with enhanced pharmacological properties, particularly in the areas of antimicrobial and anti-inflammatory agents. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibited potent activity against multidrug-resistant bacterial strains, suggesting its potential as a lead compound for new antibiotics.

In addition to its antimicrobial properties, Benzenepropanol, 2,4-dichloro-α-ethyl- has shown promise in the field of oncology. A recent preclinical study investigated its mechanism of action in inhibiting tumor cell proliferation. The results indicated that the compound interferes with key signaling pathways involved in cancer cell survival, such as the PI3K/AKT/mTOR pathway. These findings were further supported by in vivo experiments, where the compound demonstrated significant tumor growth inhibition in mouse models without causing severe toxicity. These results underscore the potential of this compound as a candidate for further development in cancer therapy.

The synthesis and optimization of Benzenepropanol, 2,4-dichloro-α-ethyl- have also been a focus of recent research. Advanced synthetic methodologies, including green chemistry approaches, have been employed to improve the yield and purity of the compound. A 2024 patent application disclosed a novel catalytic system that significantly enhances the efficiency of the synthesis process, making it more scalable for industrial production. This development is particularly important given the growing demand for this compound in both academic and industrial settings.

Despite these promising advancements, challenges remain in the full characterization and clinical translation of Benzenepropanol, 2,4-dichloro-α-ethyl-. Pharmacokinetic studies are needed to better understand its absorption, distribution, metabolism, and excretion (ADME) properties. Additionally, further toxicological assessments are required to ensure its safety profile meets regulatory standards for human use. Ongoing research efforts are addressing these gaps, with several collaborative projects between academia and pharmaceutical companies currently underway.

In conclusion, Benzenepropanol, 2,4-dichloro-α-ethyl- (CAS: 1251247-67-2) represents a promising compound with diverse applications in chemical biology and medicine. Its unique structural features and demonstrated biological activities make it a valuable tool for drug discovery and development. Future research should focus on optimizing its pharmacological properties, elucidating its mechanisms of action, and advancing it through preclinical and clinical studies. The continued exploration of this compound and its derivatives holds great potential for addressing unmet medical needs in various therapeutic areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)